|
|
Formula: C10H11N2O6PR2
There are 30 entries for this compound.
M00328: 2.7.10.1 ; ALK tyrosine kinase receptor (EC 2.7.10.1) (Anaplastic lymphoma kinase)AltName: CD_antigen=CD246; (Catalytic domain; 1.10.510.10)
M00325: 2.7.10.1 ; Angiopoietin-1 receptor (EC 2.7.10.1) (Endothelial tyrosine kinase) (Tunica interna endothelial cell kinase) (Tyrosine kinase with Ig and EGF homology domains-2) (Tyrosine-protein kinase receptor TEK) (Tyrosine-protein kinase receptor TIE-2) (hTIE2) (p140 TEK)AltName: CD_antigen=CD202b; (Catalytic domain; 1.10.510.10)
M00124: 2.7.10.1 ; Ephrin type-B receptor 2 (Catalytic domain; 1.10.510.10)
M00127: 2.7.10.1 ; Fibroblast growth factor receptor 1 (FGFR-1) (EC 2.7.10.1) (Basic fibroblast growth factor receptor 1) (BFGFR) (bFGF-R-1) (Fms-like tyrosine kinase 2) (FLT-2) (N-sam) (Proto-oncogene c-Fgr)AltName: CD_antigen=CD331; (Catalytic domain; 1.10.510.10)
M00132: 2.7.10.1 ; High affinity nerve growth factor receptor (Catalytic domain; 1.10.510.10)
M00136: 2.7.10.1 ; Insulin-like growth factor 1 receptor (EC 2.7.10.1) (Insulin-like growth factor I receptor) (IGF-I receptor)AltName: CD_antigen=CD221; (Catalytic domain; 1.10.510.10)
M00129: 2.7.10.1 ; Insulin receptor (IR) (EC 2.7.10.1)AltName: CD_antigen=CD220; (Catalytic domain; 1.10.510.10)
M00330: 2.7.10.1 ; Macrophage colony-stimulating factor 1 receptor (CSF-1 receptor) (CSF-1-R) (CSF-1R) (M-CSF-R) (EC 2.7.10.1) (Proto-oncogene c-Fms)AltName: CD_antigen=CD115; (Catalytic domain; 1.10.510.10)
M00329: 2.7.10.1 ; Macrophage-stimulating protein receptor (MSP receptor) (EC 2.7.10.1) (CDw136) (Protein-tyrosine kinase 8) (p185-Ron)AltName: CD_antigen=CD136; (Catalytic domain; 1.10.510.10)
M00323: 2.7.10.1 ; Mast/stem cell growth factor receptor Kit (SCFR) (EC 2.7.10.1) (Piebald trait protein) (PBT) (Proto-oncogene c-Kit) (Tyrosine-protein kinase Kit) (p145 c-kit) (v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog)AltName: CD_antigen=CD117; (Catalytic domain; 1.10.510.10)
M00327: 2.7.10.1 ; Muscle (Catalytic domain; 1.10.510.10)
M00326: 2.7.10.1 ; Proto-oncogene tyrosine-protein kinase receptor Ret (Catalytic domain; 1.10.510.10)
M00331: 2.7.10.1 ; Receptor-type tyrosine-protein kinase FLT3 (EC 2.7.10.1) (FL cytokine receptor) (Fetal liver kinase-2) (FLK-2) (Fms-like tyrosine kinase 3) (FLT-3) (Stem cell tyrosine kinase 1) (STK-1)AltName: CD_antigen=CD135; (Catalytic domain; 1.10.510.10)
M00332: 2.7.10.1 ; Tyrosine-protein kinase Mer (Catalytic domain; 1.10.510.10)
M00131: 2.7.10.1 ; Vascular endothelial growth factor receptor 1 (Catalytic domain; 1.10.510.10)
M00335: 2.7.10.2, 2.7.11.1 ; Activated CDC42 kinase 1 (Catalytic domain; 1.10.510.10)
M00344: 2.7.10.2 ; Cytoplasmic tyrosine-protein kinase BMX (Catalytic domain; 1.10.510.10)
M00130: 2.7.10.2 ; Tyrosine-protein kinase ABL1 (Catalytic domain; 1.10.510.10)
M00304: 2.7.10.2 ; Tyrosine-protein kinase CSK (Catalytic domain; 1.10.510.10)
M00339: 2.7.10.2 ; Tyrosine-protein kinase Fes/Fps (Catalytic domain; 1.10.510.10)
T00256: 2.7.10.2 ; Tyrosine-protein kinase Fyn (Catalytic domain; )
M00148: 2.7.10.2 ; Tyrosine-protein kinase SYK (Catalytic domain; )
M00333: 2.7.10.2 ; Tyrosine-protein kinase ZAP-70 (Catalytic domain; 1.10.510.10)
D00154: 3.1.3.16, 3.1.3.48, 3.1.3.67 ; Phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN (Catalytic domain; 3.90.190.10)
S00458: 3.1.3.16, 3.1.3.48 ; Dual specificity protein phosphatase 3 (Catalytic domain; 3.90.190.10)
S00298: 3.1.3.2, 3.1.3.48 ; Low molecular weight phosphotyrosine protein phosphatase (Catalytic domain; 3.40.50.270)
S00393: 3.1.3.48 ; M-phase inducer phosphatase 1 (Catalytic domain; 3.40.250.10)
M00149: 3.1.3.48 ; Receptor-type tyrosine-protein phosphatase F (Catalytic domain; 3.90.190.10)
T00221: 3.1.3.48 ; Tyrosine-protein phosphatase non-receptor type 11 (Catalytic domain; 3.90.190.10)
M00169: 3.1.3.48 ; Tyrosine-protein phosphatase non-receptor type 13 (Catalytic domain; 3.90.190.10)
|
|
